̽»¨¾«Ñ¡

Nouha Saleh Stattin's research

My research focuses, among other things, on developing interventions to improve early detection of prediabetes and type 2 diabetes (T2D), as well as enhancing care for individuals with these two conditions.

Nouha Saleh Stattin, docent at the Division of Family Medicine and Primary Care, NVS. Photo: Private.

Research focus

1. CoPreDia: Co-designing a behavioral change model for people with pre-diabetes: studies in primary health care

Lifestyle interventions in controlled environments reduce the incidence of diabetes, cardiovascular disease, and all-cause mortality among individuals with prediabetes. However, successfully implementing such interventions in primary care—where people with prediabetes are diagnosed and followed up—remains a challenge. Previous studies show that behavioral change interventions are more successful when the target group is involved in co-designing the efforts. Our hypothesis is therefore that if we involve both individuals with prediabetes and their healthcare providers in co-designing a behavioral change model, interventions using this model will result in sustainable change.

2. Translating and evaluating a toolbox to facilitate family involvement in self-care for people with T2D treated in primary care

The aim is to translate, culturally adapt, and pilot test the effectiveness of the Family Toolbox in Swedish primary care. This is a collaboration with the Steno Diabetes Center in Copenhagen.

3. Improved detection of cardiometabolic risk factors and type 2 diabetes in Region Stockholm

Cardiometabolic risk factors and non-communicable diseases are major causes of disability and mortality. Cardiometabolic risk factors such as high blood pressure and elevated fasting blood glucose together account for 27 percent of the disease burden in Region Stockholm. The co-occurrence of metabolic risk factors also increases the risk of T2D. Early identification and treatment of individuals with cardiometabolic risk factors or T2D can delay disease progression and prevent complications and premature death. Unfortunately, T2D often goes undetected in primary care patients, and the statistics on identified cardiometabolic risk factors in this population are incomplete. The aim of this research project is to enable more effective detection and treatment of cardiometabolic risk factors and T2D in primary care in Region Stockholm.

Collaborators and researchers

Project 1:

  • Professor Marit Graue, University of Applied Sciences, Department of Health and Caring Sciences, Begen, Norway.
  • Christina Olsson, docent, Ì½»¨¾«Ñ¡, Department of Neurobiology, Care Science and Society, Division of Physiotherapy
  • Professor Timothy Charles Skinner, Institute for Health Transformation, Department of Australian Centre for Behavioural Research in Diabetes. Australia
  • Dan Grabowski, PhD, Steno Diabetes Center Copenhagen, Department of Prevention, Health Promotion and Community Care. Copenhagen, Denmark.
  • Katri Harcke, diabetes nurse specialist, doctoral student, ̽»¨¾«Ñ¡, Department of Neurobiology, Care Science and Society, Division of Family Medicine and Primary Care. 

Projekt 3:

  • Boel Brynedal, associated professor, Centrum för epidemiologi och samhällsmedicin (CES), Region Stockholm.

Collaboration

Project 2: 

  • Dan Grabowski PhD, Researcher Leader and Senior researcher at Stena Diabetes Center Copenhagen (SDCC).

Funding

  • Diabetesfonden, Svenska Diabetesförbundet
  • Svensk förening för sjuksköterskor i diabetesvÃ¥rden – SFSD

Selected publications


Harcke K, Graue M, Skinner TC, Olsson CB, Grabowski D, Saleh-Stattin N
J Diabetes Res 2025 ;2025():8063481


Wändell P, Crump C, Li X, Stattin NS, Carlsson AC, Sundquist J, Sundquist K
J Am Heart Assoc 2024 Mar;13(5):e031125


Harcke K, Lindunger A, Kollinius E, Gebreslassie M, Ugarph Morawski A, Nylén C, Peterson M, Yucel-Lindberg T, Östenson CG, Skott P, Saleh Stattin N
Scand J Prim Health Care 2024 Mar;42(1):170-177

Delineation of the intimate details of the backbone conformation of pyridine nucleotide coenzymes in aqueous solution.
Bose KS, Sarma RH
Biochem Biophys Res Commun 1975 Oct;66(4):1173-9


Wändell P, Li X, Saleh Stattin N, Carlsson AC, Crump C, Sundquist J, Sundquist K
Diabetes Care 2023 Apr;46(4):e94-e96


Wändell P, Li X, Stattin NS, Carlsson AC, Sundquist J, Crump C, Sundquist K
Nutr Metab Cardiovasc Dis 2023 Oct;33(10):2028-2034


Harcke K, Graue M, Skinner TC, Olsson CB, Saleh-Stattin N
BMC Prim Care 2023 Dec;24(1):266


Timm L, Harcke K, Karlsson I, Sidney Annerstedt K, Alvesson HM, Stattin NS, Forsberg BC, Östenson CG, Daivadanam M
Glob Health Action 2020 Dec;13(1):1795439


Saleh Stattin N, Kane K, Stenbäck M, Wajngot A, Seijboldt K
Prim Care Diabetes 2020 Feb;14(1):33-39

Content reviewer:
20-10-2025